- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Bromonitrobenzen is a type of pharmaceutical intermediate used in the production of active pharmaceutical ingredients (APIs). It is a versatile intermediate that can be used in a variety of synthetic pathways, including the synthesis of antibiotics, anti-inflammatory drugs, and other therapeutic agents. Bromonitrobenzen is also used in the production of dyes, pigments, and other specialty chemicals.
Bromonitrobenzen is produced through a variety of methods, including nitration, bromination, and oxidation. The most common method is nitration, which involves the reaction of nitric acid with an aromatic compound. Bromonitrobenzen is also produced through the reaction of bromine with an aromatic compound.
The bromonitrobenzen market is highly competitive, with a number of manufacturers offering a wide range of products. The market is also characterized by a high degree of innovation, with manufacturers constantly developing new products and processes to meet the changing needs of the pharmaceutical industry.
Some of the major companies in the bromonitrobenzen market include Merck KGaA, BASF, Solvay, and Lonza. Other companies include Sigma-Aldrich, Alfa Aesar, and Acros Organics. Show Less Read more